Calendario de promoción Centogene N.V.
Horario avanzado
gráfico sencillo
Acerca de la empresa
Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. más detalles| EBITDA | -0.0045 |
|---|---|
| EV/EBITDA | -2.32 |
| IPO date | 2019-11-07 |
| ISIN | NL0014040206 |
| Industry | Health Care Providers & Services |
| P/BV | 2.69 |
| P/S | 3.25 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | eur |
| Выручка | 0.0405 |
| Сайт | https://www.centogene.com |
| Цена ао | 0.2238 |
| Число акций ао | 0.02681 млрд |
| Cambio de precio por día: | 0% (0.1211) |
|---|---|
| Cambio de precio por semana.: | -9.9% (0.1344) |
| Cambio de precio por mes: | +34.56% (0.09) |
| Cambio de precio en 3 meses.: | -39.45% (0.2) |
| Cambio de precio en seis meses: | -70.32% (0.408) |
| Cambio de precio por año: | -89.91% (1.2) |
| Cambio de precio en 3 años.: | -97.66% (5.17) |
| Cambio de precio en 5 años.: | -99.07% (13.05) |
| Cambio de precio en 10 años.: | 0% (0.1211) |
| Cambio de precio desde principios de año.: | 0% (0.1211) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| Platinum Investment Management Ltd | 2377150 | 8.61 |
| Wells Fargo & Company | 206389 | 0.75 |
| Acadian Asset Management. LLC | 24703 | 0.09 |
| Blackrock Inc. | 21578 | 0.08 |
| Millennium Management LLC | 19731 | 0.07 |
| Morgan Stanley | 18231 | 0.07 |
| Stifel Financial Corporation | 16450 | 0.06 |
| Barclays PLC | 15348 | 0.06 |
| Geode Capital Management, LLC | 11156 | 0.04 |
| Meeder Asset Management, Inc. | 138 | 0 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Ms. Kim Stratton | CEO & Member of Management Board | 932.62k | 1962 (63 año) |
| Mr. Jose Miguel Coego Rios | CFO, Legal & IT and Member of Management Board | 323.87k | 1974 (51 año) |
| Dr. Peter Bauer M.D. | Interim MD, Chief Medical & Genomic Officer and Member of Management Board | 186.31k | 1970 (55 años) |
| Dr. Andrin Oswald M.D., Ph.D. | Advisor | 943.45k | 1972 (53 año) |
| Mr. Ian Rentsch | Chief Commercial Officer & GM of Pharma | N/A | 1976 (49 años) |
DIRECCIÓN: Germany, Rostock, Am Strande 7 - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.centogene.com
Sitio web: https://www.centogene.com
